Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
62 participants
OBSERVATIONAL
2009-12-22
2012-11-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nanoparticles Emitted by Aircraft Engines, Impact on the Respiratory Function:
NCT02872727
Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles
NCT03839537
Nanoparticles Emitted by Aircraft Engines, Impact on Respiratory Function
NCT03098784
Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air Pollution Exposure
NCT04549142
Sympathetic Nerve Activation Evoked by Diesel Exhaust Exposure
NCT02892279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Experimental studies have suggested the transplacental passage of asbestos fibers, but despite the strong growth in the use and production of fine and ultrafine particles, no study has examined the permeability of the placenta to these compounds or the exposures fetuses that may result.
The objective of this study is to evaluate the transplacental passage of fine and ultrafine particles (nanoparticles) inhaled by the mother.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulmonary Tissue Collection
Pulmonary Tissue Collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Fetus with malformation syndrome affecting pulmonary perfusion.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivia OCHRYMCZUK, Dr
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2008/04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.